There are 2137 resources available
LBA28 - A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial
Presenter: Mansoor Raza Mirza
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
806O - Radical hysterectomy in cervical cancer patients with intraoperatively detected positive lymph node: ABRAX multicentric retrospective cohort study (ENGOT-Cx3/CEEGOG CX2)
Presenter: David Cibula
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
LBA29 - Individualized starting dose of niraparib in Chinese patients with platinum-sensitive recurrent ovarian cancer (PSROC): A randomized, double-blind, placebo-controlled, phase III trial (NORA)
Presenter: Xiaohua Wu
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
LBA30 - INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
Presenter: Nicoletta Colombo
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
CN27 - Value of nurse navigators (NNs) telemonitoring for cancer patients (pts) tested positive for COVID-19
Presenter: Delphine Mathivon
Session: EONS13: Evolving roles in cancer nursing
Resources:
Abstract
Slides
Webcast
CN11 - How do patients value the role of the breast care nurse in the Catalan Institute of Oncology?
Presenter: Ana Rodriguez-ortega
Session: EONS13: Evolving roles in cancer nursing
Resources:
Abstract
Slides
Webcast
396O - Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study
Presenter: Thierry André
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast
397O - Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study
Presenter: Erika Martinelli
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast
398O - Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer (CRC) - PRODIGE 13 a FFCD phase III trial
Presenter: Come Lepage
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast
399O - Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trial
Presenter: Sara Lonardi
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast